Springer Nature AG & Co. KGaA (SPGDF)
| Market Cap | 4.77B -2.0% |
| Revenue (ttm) | 2.23B +4.2% |
| Net Income | 374.27M +99.1% |
| EPS | 1.84 +103.7% |
| Shares Out | n/a |
| PE Ratio | 12.21 |
| Forward PE | 12.35 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,013 |
| Open | 22.50 |
| Previous Close | n/a |
| Day's Range | 22.50 - 22.50 |
| 52-Week Range | 0.01 - 22.82 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 17, 2026 |
About SPGDF
Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health. It offers journals across various academic disciplines under the Nature Portfolio and Springer brand names; books in print and digital formats across various scientific disciplines, including monographs, textbooks, conference proceedings, handbook series, reference works, and briefs under the Springer... [Read more]
Financial Performance
In 2025, SPGDF's revenue was 1.93 billion, an increase of 4.29% compared to the previous year's 1.85 billion. Earnings were 355.70 million, an increase of 420.79%.
Financial numbers in EUR Financial StatementsNews
Springer Nature initiated with a Buy at Citi
Citi initiated coverage of Springer Nature (SPGDF) with a Buy rating and EUR 27 price target The company is benefiting from exposure to full open access growth and AI, the…
EQS-PVR: Springer Nature AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Springer Nature AG & Co. KGaA Springer Nature AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objecti...
Springer Nature AG & Co. KGaA Earnings Call Transcript: Q2 2026
Underlying revenue grew 6% and AOP 8% in H1 2026, led by the research segment and strong open access performance. Updated guidance expects ~6% revenue growth and margin improvement for the year, with robust cash flow and reduced leverage.
Springer Nature AG & Co. KGaA Quarterly report: Q2 2026
Springer Nature AG & Co. KGaA has published its Q2 2026 quarterly earnings report on August 5, 2026.
Springer Nature AG & Co. KGaA Earnings release: Q2 2026
Springer Nature AG & Co. KGaA released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
Springer Nature AG & Co. KGaA Slides: Q2 2026
Springer Nature AG & Co. KGaA has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 5, 2026.
Springer Nature AG & Co. KGaA Slides: Investor presentation
Springer Nature AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on June 25, 2026.
Springer Nature price target raised to EUR 26.90 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Springer Nature (SPGDF) to EUR 26.90 from EUR 24.30 and keeps an Overweight rating on the shares.
Springer Nature AG & Co. KGaA Earnings Call Transcript: Q1 2026
Q1 2026 saw 6% underlying revenue and 9% AOP growth, led by research and open access. Free cash flow rose to EUR 204 million, leverage dropped to 1.5x, and full-year guidance is reiterated. AI tools and new journal launches support continued outperformance.
Springer Nature AG & Co. KGaA Slides: Q1 2026
Springer Nature AG & Co. KGaA has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
Springer Nature AG & Co. KGaA Quarterly report: Q1 2026
Springer Nature AG & Co. KGaA has published its Q1 2026 quarterly earnings report on May 5, 2026.
Springer Nature AG & Co. KGaA Slides: Company presentation
Springer Nature AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on April 15, 2026.
Springer Nature price target lowered to EUR 31 from EUR 31.50 at JPMorgan
JPMorgan lowered the firm’s price target on Springer Nature (SPGDF) to EUR 31 from EUR 31.50 and keeps an Overweight rating on the shares.
Springer Nature price target raised to EUR 31.50 from EUR 31 at JPMorgan
JPMorgan analyst Daniel Kerven raised the firm’s price target on Springer Nature (SPGDF) to EUR 31.50 from EUR 31 and keeps an Overweight rating on the shares. Published first on…
Springer Nature price target raised to EUR 24.30 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Springer Nature (SPGDF) to EUR 24.30 from EUR 23.90 and keeps an Overweight rating on the shares.
Springer Nature price target raised to EUR 31 from EUR 29 at Deutsche Bank
Deutsche Bank analyst Steve Liechti raised the firm’s price target on Springer Nature (SPGDF) to EUR 31 from EUR 29 and keeps a Buy rating on the shares. Published first…
Springer Nature AG & Co. KGaA Earnings Call Transcript: Q4 2025
Delivered strong 2025 results with 6% underlying revenue and 9% AOP growth, led by research and open access. 2026 guidance targets 5%-6% revenue growth and further margin expansion, supported by high renewal rates, robust submissions, and ongoing AI-driven efficiencies.
Springer Nature AG & Co. KGaA Annual report: Q4 2025
Springer Nature AG & Co. KGaA has published its Q4 2025 annual report on March 17, 2026.
Springer Nature AG & Co. KGaA Earnings release: Q4 2025
Springer Nature AG & Co. KGaA released its Q4 2025 earnings on March 17, 2026, summarizing the period's financial results.
Springer Nature AG & Co. KGaA Slides: Q4 2025
Springer Nature AG & Co. KGaA has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 17, 2026.
Springer Nature price target lowered to EUR 31 from EUR 31.10 at JPMorgan
JPMorgan lowered the firm’s price target on Springer Nature (SPGDF) to EUR 31 from EUR 31.10 and keeps an Overweight rating on the shares.
Springer Nature price target raised to EUR 31.10 from EUR 30.50 at JPMorgan
JPMorgan analyst Daniel Kerven raised the firm’s price target on Springer Nature (SPGDF) to EUR 31.10 from EUR 30.50 and keeps an Overweight rating on the shares. Published first on…